Eton Pharmaceuticals, Inc. (ETON)
63.22
-1.21
(-1.88%)
USD |
NASDAQ |
Aug 25, 13:45
Eton Pharmaceuticals Shareholders Equity (Quarterly) : 46.58M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 46.58M |
| March 31, 2026 | 30.62M |
| December 31, 2025 | 26.15M |
| September 30, 2025 | 23.13M |
| June 30, 2025 | 23.96M |
| March 31, 2025 | 24.45M |
| December 31, 2024 | 24.43M |
| September 30, 2024 | 15.98M |
| June 30, 2024 | 13.46M |
| March 31, 2024 | 15.49M |
| December 31, 2023 | 15.48M |
| September 30, 2023 | 16.89M |
| June 30, 2023 | 16.72M |
| March 31, 2023 | 11.24M |
| December 31, 2022 | 13.08M |
| September 30, 2022 | 11.18M |
| June 30, 2022 | 13.24M |
| March 31, 2022 | 13.38M |
| Date | Value |
|---|---|
| December 31, 2021 | 17.63M |
| September 30, 2021 | 15.66M |
| June 30, 2021 | 20.74M |
| March 31, 2021 | 21.56M |
| December 31, 2020 | 15.66M |
| September 30, 2020 | 1.388M |
| June 30, 2020 | 7.031M |
| March 31, 2020 | 10.62M |
| December 31, 2019 | 10.55M |
| September 30, 2019 | 12.35M |
| June 30, 2019 | 16.70M |
| March 31, 2019 | 19.24M |
| December 31, 2018 | 26.30M |
| September 30, 2018 | 4.751M |
| June 30, 2018 | 7.496M |
| March 31, 2018 | 10.16M |
| December 31, 2017 | 12.13M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Nektar Therapeutics | 903.12M |
| Pfizer Inc. | 85.19B |
| Elite Pharmaceuticals, Inc. | 104.83M |
| Daré Bioscience, Inc. | -0.5601M |
| Liquidia Corp. | 195.11M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 115.81M |
| Total Liabilities (Quarterly) | 69.22M |
| Debt to Equity Ratio | 0.6273 |
| Current Ratio | 1.520 |
| Net Debt Paydown Yield | 0.02% |